12 weeks treatment with 500 mg roflumilast versus 400 mg beclomethasone dipropionate in patients with asthma. A double-blind, double dummy, randomized parallel group study

*Please Note* The Study you are attempting to view was acquired from Takeda by AstraZeneca and was disclosed initially by Takeda per their Transparency Policies. More information regarding this study may be available by contacting [email protected].

A phase 3, multi-center, double-blind, double-dummy, randomized, parallel-group, study with a single-blind placebo baseline period in subjects with bronchial asthma.